share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  May 20 20:06

Gainers

  • GT Biopharma (NASDAQ:GTBP) stock rose 153.2% to $7.9 during Monday's pre-market session. The company's market cap stands at $10.9 million. As per the press release, Q1 earnings came out 3 days ago.
  • China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) shares rose 42.9% to $0.47. As per the news, the Q1 earnings report came out 3 days ago.
  • Kintara Therapeutics (NASDAQ:KTRA) shares rose 28.95% to $0.18. The market value of their outstanding shares is at $7.1 million. The company's, Q3 earnings came out 4 days ago.
  • PTC Therapeutics (NASDAQ:PTCT) stock rose 26.9% to $42.0. The market value of their outstanding shares is at $3.2 billion.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 25.21% to $1.44. The company's market cap stands at $1.3 million.
  • Cue Health (NASDAQ:HLTH) stock rose 24.48% to $0.12. The company's market cap stands at $19.0 million.

Losers

  • Virios Therapeutics (NASDAQ:VIRI) shares fell 44.1% to $0.2 during Monday's pre-market session. The company's market cap stands at $3.7 million.
  • Jaguar Health (NASDAQ:JAGX) shares fell 39.46% to $0.16. The market value of their outstanding shares is at $45.9 million. The company's, Q1 earnings came out 4 days ago.
  • Aesthetic Medical Intl (NASDAQ:AIH) shares fell 27.68% to $0.36. The company's market cap stands at $17.2 million.
  • Akanda (NASDAQ:AKAN) shares declined by 23.01% to $0.13. The company's market cap stands at $4.2 million.
  • Syra Health (NASDAQ:SYRA) shares decreased by 11.95% to $1.4. The market value of their outstanding shares is at $8.9 million.
  • Tenon Medical (NASDAQ:TNON) shares decreased by 9.58% to $0.77. The company's market cap stands at $2.8 million. As per the press release, Q1 earnings came out 4 days ago.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment